eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
3/2020
vol. 16
 
Share:
Share:
more
 
 
abstract:
Image in intervention

Simultaneous multivessel percutaneous coronary intervention and transfemoral transcatheter aortic valve implantation with ACURATE neo

Michał Hawranek
1
,
Kamil Bujak
1
,
Jan Rychter
2
,
Mariusz Gąsior
1
,
Michal Zembala
2

1.
3rd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Poland
2.
Division of Cardiac Surgery, Heart and Lung Transplantation and Mechanical Circulatory Support, Silesian Center for Heart Disease, Zabrze, Poland
Adv Interv Cardiol 2020; 16, 3 (61): 349–351
Online publish date: 2020/10/02
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Coronary artery disease (CAD), due to common risk factors, often accompanies aortic stenosis (AS) [1]. CAD occurs in 50–75% of patients undergoing transcatheter aortic valve implantation (TAVI) [1]. However, there are no data on the necessity and the extent of revascularization in CAD patients referred for TAVI. According to the ESC/EACTS guidelines for myocardial revascularization published in 2018, percutaneous coronary intervention (PCI) should be considered in patients with stenoses > 70% in proximal segments of coronary arteries, undergoing TAVI [2]. Optimal timing (before, simultaneously or after TAVI) and the mode of revascularization have not yet been established [2].
Quick links
© 2020 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe